Elsevier

The Lancet

Volume 342, Issue 8885, 11 December 1993, Pages 1441-1446
The Lancet

Articles
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy

https://doi.org/10.1016/0140-6736(93)92930-RGet rights and content

Abstract

Several small studies have suggested beneficial effects of long-term β-blocker treatment in idiopathic dilated cardiomyopathy. Our large multicentre study aimed to find out whether metoprolol improves overall survival and morbidity in this disorder. 383 subjects with heart failure from idiopathic dilated cardiomyopathy (ejection fraction <0 40) were randomly assigned placebo or metoprolol. 94% were in New York Heart Association functional classes II and III, and 80% were receiving background treatment. A test dose of metoprolol (5 mg twice daily) was given for 2-7 days; those tolerating this dose (96%) entered randomisation. Study medication was increased slowly from 10 mg to 100-150 mg daily. There were 34% (95% Cl-6 to 62%, p=0·058) fewer primary endpoints in the metoprolol than the placebo group; 2 and 19 patients, respectively, deteriorated to the point of needing transplantation and 23 and 19 died. The change in ejection fraction from baseline to 12 months was significantly greater with metoprolol than with placebo (0·13 vs 0·06, p<0·0001). Pulmonary capillary wedge pressure decreased more from baseline to 12 months with metoprolol than with placebo (5 vs 2 mm Hg, p=0 06). Exercise time at 12 months was significantly greater (p=0·046) in metoprolol-treated than in placebo-treated patients. In patients with idiopathic dilated cardiomyopathy, treatment with metoprolol prevented clinical deterioration, improved symptoms and cardiac function, and was well tolerated.

References (31)

  • H. Ikram et al.

    Double-blind trial of chronic oral β-blockade in congestive cardiomyopathy

    Lancet

    (1981)
  • Mr Bristow et al.

    Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts

    N Engl J Med

    (1982)
  • J.F. Spann et al.

    Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure

    Circ Res

    (1967)
  • F. Waagstein et al.

    β-blockers in dilated cardiomyopathies: they work

    Eur Heart J

    (1983)
  • Rs Engelmeier et al.

    Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

    Circulation

    (1985)
  • Cited by (0)

    View full text